The Prostate

Cover image for The Prostate

15 June 2007

Volume 67, Issue 9

Pages 907–1009

  1. Rapid Communications

    1. Top of page
    2. Rapid Communications
    3. Original Articles
    1. Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate (pages 907–910)

      Maryla Krajewska, Allen H. Olson, Dan Mercola, John C. Reed and Stan Krajewski

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20578

  2. Original Articles

    1. Top of page
    2. Rapid Communications
    3. Original Articles
    1. Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk (pages 911–923)

      Bahar Mikhak, David J Hunter, Donna Spiegelman, Elizabeth A. Platz, Bruce W. Hollis and Edward Giovannucci

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20570

    2. Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer (pages 933–942)

      Masanori Noguchi, Akihisa Yao, Mamoru Harada, Osamu Nakashima, Yoshihiro Komohara, Satoko Yamada, Kyogo Itoh and Kei Matsuoka

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20572

    3. Labeling and identification of LNCaP cell surface proteins: A pilot study (pages 943–954)

      Hayley C. Whitaker, David P.B. Stanbury, Claire Brinham, Joanne Girling, Sarah Hanrahan, Nick Totty and David E. Neal

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20580

    4. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines (pages 955–967)

      Masashi Takeda, Atsushi Mizokami, Kiminori Mamiya, You Qiang Li, Jian Zhang, Evan T. Keller and Mikio Namiki

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20581

    5. Vascular density is highest in the proximal region of the mouse prostate (pages 968–975)

      Gui-Min Wang, Bruce Kovalenko, E. Lynette Wilson and David Moscatelli

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20582

    6. Lithium suppresses cell proliferation by interrupting E2F–DNA interaction and subsequently reducing S–phase gene expression in prostate cancer (pages 976–988)

      Aijing Sun, Ilanchezian Shanmugam, Jiawu Song, Paul F. Terranova, J. Brantley Thrasher and Benyi Li

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20586

    7. Late fetal death in offspring and subsequent incidence of prostate cancer in fathers: The Jerusalem Perinatal Study cohort (pages 989–998)

      S. Harlap, Y. Friedlander, M. Barchana, R. Calderon, L. Deutsch, K.R. Kleinhaus, M.C. Perrin, E. Tiram, R. Yanetz and O. Paltiel

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20591

    8. The bisphosphonate YM529 inhibits osteoblastic bone tumor proliferation of prostate cancer (pages 999–1009)

      Hiroyuki Yonou, Atsushi Ochiai, Satoshi Ashimine, Hiroyuki Maeda, Yutaka Horiguchi, Kunihiko Yoshioka, Yoshihide Ogawa, Tadashi Hatano and Masaaki Tachibana

      Version of Record online: 17 APR 2007 | DOI: 10.1002/pros.20592

SEARCH

SEARCH BY CITATION